Hartvigsen J, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356–67.
Urits I, et al. Low back pain, a comprehensive review: pathophysiology, diagnosis, and treatment. Curr Pain Headache Rep. 2019;23(3):23.
Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–47.
Liu F, et al. Molecular mechanism of mechanical pressure induced changes in the microenvironment of intervertebral disc degeneration. Inflamm Res. 2024;73(12):2153–64.
Song C, et al. Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration. Pharmacol Res. 2024;202: 107119.
Zhou D, et al. Analysis of the role of PANoptosis in intervertebral disk degeneration via integrated bioinformatics analysis and experimental validation. Int Immunopharmacol. 2024;143(Pt 3): 113528.
Zhou D, et al. Exploration of the mode of death and potential death mechanisms of nucleus pulposus cells. Eur J Clin Invest. 2024;54(9): e14226.
Song C, et al. Mitochondrial dysfunction: a new molecular mechanism of intervertebral disc degeneration. Inflamm Res. 2023;72(12):2249–60.
Song C, et al. Cellular senescence - molecular mechanisms of intervertebral disc degeneration from an immune perspective. Biomed Pharmacother. 2023;162: 114711.
Song C, et al. An in-depth analysis of the immunomodulatory mechanisms of intervertebral disc degeneration. JOR Spine. 2022;5(4): e1233.
Binch AL, et al. Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. Arthritis Res Ther. 2014;16(5):416.
Xin J, et al. Treatment of intervertebral disc degeneration. Orthop Surg. 2022;14(7):1271–80.
Cannizzaro D, et al. Lumbar adjacent segment degeneration after spinal fusion surgery: a systematic review and meta-analysis. J Neurosurg Sci. 2023;67(6):740–9.
Krut Z, et al. Stem cells and exosomes: new therapies for intervertebral disc degeneration. Cells. 2021. https://doi.org/10.3390/cells10092241.
Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44–56.
Xing H, et al. Injectable exosome-functionalized extracellular matrix hydrogel for metabolism balance and pyroptosis regulation in intervertebral disc degeneration. J Nanobiotechnology. 2021;19(1):264.
Kirnaz S, et al. Fundamentals of intervertebral disc degeneration. World Neurosurg. 2022;157:264–73.
Kang L, et al. Epigenetic modifications of inflammation in intervertebral disc degeneration. Ageing Res Rev. 2023;87: 101902.
Xia Q, et al. Progress in the study of molecular mechanisms of intervertebral disc degeneration. Biomed Pharmacother. 2024;174: 116593.
Xu H, et al. Contribution of immune cells to intervertebral disc degeneration and the potential of immunotherapy. Connect Tissue Res. 2023;64(5):413–27.
Mohd Isa IL, et al. Discogenic low back pain: anatomy, pathophysiology and treatments of intervertebral disc degeneration. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms24010208.
Zhao L, et al. Treatment of discogenic low back pain: current treatment strategies and future options-a literature review. Curr Pain Headache Rep. 2019;23(11):86.
Cazzanelli P, Wuertz-Kozak K. Micrornas in intervertebral disc degeneration, apoptosis, inflammation, and mechanobiology. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21103601.
Li H, et al. The roles of circRNAs in intervertebral disc degeneration: inflammation, extracellular matrix metabolism, and apoptosis. Anal Cell Pathol (Amst). 2022;2022:9550499.
Li M, et al. Genkwanin alleviates intervertebral disc degeneration via regulating ITGA2/PI3K/AKT pathway and inhibiting apoptosis and senescence. Int Immunopharmacol. 2024;133: 112101.
Silwal P, et al. Cellular senescence in intervertebral disc aging and degeneration: molecular mechanisms and potential therapeutic opportunities. Biomolecules. 2023. https://doi.org/10.3390/biom13040686.
Xu J, et al. Aging, cell senescence, the pathogenesis and targeted therapies of intervertebral disc degeneration. Front Pharmacol. 2023;14:1172920.
He X, et al. Cellular senescence in skeletal disease: mechanisms and treatment. Cell Mol Biol Lett. 2023;28(1):88.
Koroth J, et al. Macrophages and intervertebral disc degeneration. Int J Mol Sci. 2023;24(2).
Zhang GZ, et al. Sirtuins and intervertebral disc degeneration: roles in inflammation, oxidative stress, and mitochondrial function. Clin Chim Acta. 2020;508:33–42.
Wang Y, et al. The role of IL-1β and TNF-α in intervertebral disc degeneration. Biomed Pharmacother. 2020;131: 110660.
Li H, et al. The mechanisms and functions of IL-1β in intervertebral disc degeneration. Exp Gerontol. 2023;177: 112181.
Johnson ZI, et al. Disc in flames: roles of TNF-α and IL-1β in intervertebral disc degeneration. Eur Cell Mater. 2015;30:104–16 discussion 116–7.
Meng Q, et al. Digoxin protects against intervertebral disc degeneration via TNF/NF-κB and LRP4 signaling. Front Immunol. 2023;14:1251517.
Zhou T, et al. Mechanism of microRNA-146a-mediated IL-6/STAT3 signaling in lumbar intervertebral disc degeneration. Exp Ther Med. 2017;14(2):1131–5.
Tan JH, et al. IL-17 in intervertebral disc degeneration: mechanistic insights and therapeutic implications. Cell Biol Int. 2022;46(4):535–47.
Peng B, et al. Research on the role and mechanism of IL-17 in intervertebral disc degeneration. Int Immunopharmacol. 2024;132: 111992.
Liu X, et al. Glycyrrhizin suppresses inflammation and cell apoptosis by inhibition of HMGB1 via p38/p-JUK signaling pathway in attenuating intervertebral disc degeneration. Am J Transl Res. 2019;11(8):5105–13.
Fu B, et al. HMGB1-induced autophagy promotes extracellular matrix degradation leading to intervertebral disc degeneration. Int J Clin Exp Pathol. 2020;13(9):2240–8.
Chen S, et al. Grem1 accelerates nucleus pulposus cell apoptosis and intervertebral disc degeneration by inhibiting TGF-β-mediated Smad2/3 phosphorylation. Exp Mol Med. 2022;54(4):518–30.
Wu J, et al. Self-amplifying loop of NF-κB and periostin initiated by PIEZO1 accelerates mechano-induced senescence of nucleus pulposus cells and intervertebral disc degeneration. Mol Ther. 2022;30(10):3241–56.
Dong X, et al. DPSCs protect architectural integrity and alleviate intervertebral disc degeneration by regulating nucleus pulposus immune status. Stem Cells Int. 2022;2022:7590337.
Gong Y, et al. Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis. Inflammopharmacology. 2023;31(1):369–84.
Zhao Y, Li A. MiR-19b-3p relieves intervertebral disc degeneration through modulating PTEN/PI3K/Akt/mTOR signaling pathway. Aging (Albany NY). 2021;13(18):22459–73.
Kim JH, Ham CH, Kwon WK. Current knowledge and future therapeutic prospects in symptomatic intervertebral disc degeneration. Yonsei Med J. 2022;63(3):199–210.
Hasanpour F, et al. Activation of the TrkA/Ras-MAPK/ERK signaling pathway via carbon quantum dot mimetics for enhanced peripheral nerve regeneration. Neurochem Res. 2025;50(4):222.
Xiang Q, Zhao Y, Li W. Identification and validation of ferroptosis-related gene signature in intervertebral disc degeneration. Front Endocrinol (Lausanne). 2023;14: 1089796.
Sugiura A, et al. Existence of nerve growth factor receptors, tyrosine kinase A and p75 neurotrophin receptors in intervertebral discs and on dorsal root ganglion neurons innervating intervertebral discs in rats. Spine (Phila Pa 1976). 2008;33(19):2047–51.
Li K, et al. A structured biomimetic nanoparticle as inflammatory factor sponge and autophagy-regulatory agent against intervertebral disc degeneration and discogenic pain. J Nanobiotechnology. 2024;22(1):486.
Zhang S, et al. Extracellular matrix in intervertebral disc: basic and translational implications. Cell Tissue Res. 2022;390(1):1–22.
Vergroesen PP, et al. Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthritis Cartilage. 2015;23(7):1057–70.
Peng B, et al. Research progress in decellularized extracellular matrix hydrogels for intervertebral disc degeneration. Biomater Sci. 2023;11(6):1981–93.
Eda H, et al. Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts. Rheumatol Int. 2011;31(11):1525–30.
Lisiewski LE, et al. Intradiscal inflammatory stimulation induces spinal pain behavior and intervertebral disc degeneration in vivo. Faseb j. 2024;38(1): e23364.
Lai A, et al. Spinal cord sensitization and spinal inflammation from an in vivo rat endplate injury associated with painful intervertebral disc degeneration. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms24043425.
Brisby H. Pathology and possible mechanisms of nervous system response to disc degeneration. J Bone Joint Surg Am. 2006;88(Suppl 2):68–71.
Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J. 2005;24(24):4211–23.
Comments (0)